The Fund supports several networks of state health policymakers to help identify, inspire, and inform policy leaders.
The Fund identifies and shares policy ideas and analysis on topics important to state health policymakers, particularly on issues related to state leadership, primary care, aging, and total costs of care.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
Robert A. Aronowitz
Back to The Milbank Quarterly
American medical researchers who investigated Lyme disease in the 1970s conceived of the disorder as a categorically new entity. Other interpretations emphasizing the continuities between Lyme disease and its epidemiological antecedents, nevertheless, were possible. Clinicians, patients, and advocacy groups continue to contest the character, significance, and appropriate treatment of Lyme disease. Highly publicized discussions among the interested parties reflect American society’s ongoing concern with new legitimating diagnoses, personal responsibility for acute and chronic disease, and the authority of science.
Author(s): Robert A. Aronowitz
Download the Article
Read on JSTOR
Volume 69, Issue 1 (pages 79–112) Published in 1991
Get the Latest from the Milbank Memorial Fund
The Milbank Quarterly’s multidisciplinary approach and commitment to applying the best empirical research to practical policymaking offers in-depth assessments of the social, economic, historical, legal, and ethical dimensions of health and health care policy.